Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation
Authors:
Open Access
- 22 August 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 19 (11) , 718-726
Abstract
Intrauterine infection is still a common trigger of preterm delivery (PTD) and also a determinant risk factor for the subsequent development of neurodevelopmental abnormalities in neonates. In this study, we examined the expressional pattern of various inflammatory cytokines such as interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in placentae complicated with severe chorioamnionitis (CAM) and found that IL-6 is mainly expressed in macrophages in villous mesenchyme by immunohistochemical analysis with anti-CD-68 antibody. Using an experimental lipopolysaccharide (LPS)-induced PTD model, the therapeutic potential of targeting this cytokine was investigated. Anti-IL-6 receptor antibody (MR16-1) was delivered 6 h before LPS treatment. Mice in the MR16-1 group had a significantly lower rate of PTD (17%) than in the controls (53%, P = 0.026). As a result, MR16-1 treatment significantly prolonged the gestational period (control; 18.4 ± 1.7d, MR16-1; 19.8 ± 1.5d, P = 0.007) without any apparent adverse events on the mice and their pups. In primary human amniotic epithelial cells, pretreatment with a humanized anti-human IL-6 receptor antibody, tocilizumab, significantly inhibited the production of prostaglandin E2 induced by IL-6. In conclusion, IL-6 was strongly expressed mainly in macrophages in villous mesenchyme in placentae complicated with CAM. Anti-IL-6R antibody significantly decreased the rate of PTD in LPS-induced inflammatory model in mice, and inhibited PGE2 production from human primary amniotic epithelial cells. Targeting IL-6 signaling could be a promising option for the prevention of PTD and needs to be further explored for future clinical application.Keywords
This publication has 39 references indexed in Scilit:
- The Roles of Prostaglandin EP 1 and 3 Receptors in the Control of Human Myometrial ContractilityThe Journal of Clinical Endocrinology & Metabolism, 2012
- The Role of Chemokines in Term and Premature Rupture of the Fetal Membranes: A Review1Biology of Reproduction, 2010
- Intra-amniotic surfactant for women at risk of preterm birth for preventing respiratory distress in newbornsCochrane Database of Systematic Reviews, 2010
- Mechanisms of Leukocyte Accumulation and Activation in Chorioamnionitis: Interleukin 1β and Tumor Necrosis Factor Α Enhance Colony Stimulating Factor 2 Expression in Term DeciduaReproductive Sciences, 2009
- Predictive value of combined amniotic fluid proteomic biomarkers and interleukin-6 in preterm labor with intact membranesAmerican Journal of Obstetrics and Gynecology, 2009
- Two pathways for prostaglandin F2α synthesis by the primate periovulatory follicleReproduction, 2008
- Nuclear Factor-Kappa B Regulates Inducible Prostaglandin E Synthase Expression in Human Amnion Mesenchymal Cells1Biology of Reproduction, 2008
- Prediction of survival for preterm births by weight and gestational age: retrospective population based studyBMJ, 1999
- The role of prostaglandins in human parturitionAnnals of Medicine, 1998
- Decidual cell biosynthesis of interleukin-6: regulation by inflammatory cytokinesThe Journal of Clinical Endocrinology & Metabolism, 1992